How Do Antibiotics Work and How Bacteria Resist Them (Video)

Written guide: Target Protection in Antibiotic Resistance

This video explains how the main groups of antibiotics attack bacteria, starting from the bacterial growth curve, and how bacteria become resistant.

Watch on YouTube

Chapters

  1. 0:00 How do antibiotics work
  2. 1:06 How bacteria divide
  3. 3:22 The bacterial growth curve
  4. 5:48 Measuring bacterial growth
  5. 7:39 What antibiotics target
  6. 9:14 How antibiotics work
  7. 12:52 Killing or stopping growth
  8. 15:19 How bacteria resist antibiotics
  9. 17:04 How resistance spreads
  10. 19:21 Review and question
Video transcript

0:00 How do antibiotics work

In this lesson, we will learn how antibiotics work, starting with how bacteria grow and divide. Bacteria multiply by dividing in two, and antibiotics treat bacterial infections by killing bacteria or by stopping their growth. Antibiotics are the main treatment for bacterial infections, but some bacteria become resistant, which means they keep growing at drug concentrations that once stopped their growth, and in 2019 resistant infections directly caused an estimated 1.27 million deaths worldwide. First, we will follow a single bacterial cell as it divides, and then we will see how a whole population grows in a flask and how a laboratory measures that growth. With that foundation, we will look at the parts of a bacterial cell that antibiotics attack, why those targets spare our own cells, and how different antibiotics act on those targets. In the final sections, we will learn how bacteria resist antibiotics and how resistance spreads from cell to cell, but first we need to see how a single bacterial cell divides in two.

1:06 How bacteria divide

A population of bacteria, whether in a flask or in an infection, grows because its cells divide, so we begin with how one bacterial cell becomes two. Most bacteria divide by binary fission, the division of one cell into two identical daughter cells. First, the cell grows longer and copies its single circular chromosome. The two copies of the chromosome then move toward opposite ends of the cell. Next, a ring of a protein called FtsZ forms around the middle of the cell, and a cross wall called the septum grows inward from this ring. When the septum closes, the cell splits into two daughter cells, each with a full copy of the chromosome. The time a population needs to double in number is the generation time, also called the doubling time. Escherichia coli, or E. coli, grown in a rich broth at 37 degrees Celsius, doubles in about 20 minutes. Many other bacteria take 1 to 3 hours to double, and Mycobacterium tuberculosis, the cause of tuberculosis, needs about 15 to 20 hours. Because each cell gives rise to two, the number of cells doubles in each generation, from one cell to two, then four, eight and sixteen. We can write this doubling as an equation, N equals N zero times two to the power n. Here, N zero is the number of cells at the start, n is the number of generations, and N is the number of cells at the end. To find n, we divide the time that has passed by the generation time. As an example, suppose a culture starts with 1,000 E. coli cells and grows for 2 hours with a generation time of 20 minutes. Two hours is 120 minutes, and 120 divided by 20 gives 6 generations. Two to the power 6 is 64, so the culture now holds 1,000 times 64, or 64,000 cells. The same arithmetic shows how quickly doubling adds up, because a single cell that doubles 30 times gives about 1.07 billion cells, and at 20 minutes per generation those 30 doublings take only 10 hours. This steady doubling is called exponential growth, and in a real culture it cannot continue for long, because the cells use up their food.

3:22 The bacterial growth curve

Now that we know how a population doubles, we can follow what happens when bacteria grow in a flask with a limited amount of food. A flask of broth that receives a few cells and nothing else afterward is a batch culture, a closed system with a fixed supply of nutrients and no way for waste to leave. If we count the cells in a batch culture each hour and plot the counts against time, we get the bacterial growth curve. Microbiologists plot the number of cells on a logarithmic scale, because the counts rise from about a thousand to about a billion cells per milliliter. On an ordinary linear axis, the early hours look flat and the later hours shoot upward, but on a log scale, exponential growth becomes a straight line. The curve has four phases, and the first is the lag phase. During the lag phase, the cells adjust to the new medium and make the enzymes, ribosomes and other molecules they need for growth. The cells may get larger, but their number barely rises, and the length of the lag depends on the condition of the cells and on how different the new medium is from the old. Once the cells are ready, the culture enters the log phase, also called the exponential phase. In this phase the cells divide at a constant rate, the fastest rate the conditions allow, so on the log scale the curve rises as a straight line whose slope reflects the growth rate. Cells in log phase are the most uniform in size and activity, so microbiologists use log-phase cultures when they need cells in a consistent state. Growth slows as the nutrients run low and waste products build up, and the culture enters the stationary phase. Some cells still divide in the stationary phase, but about as many cells die as form, so the total number stays roughly constant. The cells switch on genes that help them survive, and some species, such as Bacillus, form tough endospores. The last phase is the death phase, also called the decline phase, in which more cells die than divide. The number of living cells falls exponentially, so on the log scale the death phase appears as a straight line sloping downward. The decline is usually slower than the rise, and a few cells can stay alive for a long time. The growth curve therefore has four phases, lag, log, stationary and death, and the next question is how a laboratory measures each point on the curve.

5:48 Measuring bacterial growth

Each point on the growth curve comes from a measurement of the culture, and laboratories use two standard methods to make this measurement. The faster method measures optical density in a spectrophotometer. The instrument shines light with a wavelength of 600 nanometers through a sample of the culture in a small cuvette, and a detector on the far side measures how much light gets through. Cells scatter the light, so a denser culture lets less light reach the detector and gives a higher OD600 reading. The reading takes seconds, but it follows the total mass of cells, living and dead, and it tracks cell number only over a limited range. To turn optical density into cells per milliliter, a laboratory prepares a standard curve that matches OD600 readings to plate counts of the same cultures. The plate count is the second method, and it counts only living cells. We dilute the culture in a series of tenfold steps, spread a small volume of a dilution, often 0.1 milliliter, on an agar plate, and incubate the plate until colonies appear. A plate with 30 to 300 colonies gives a reliable count. Each colony grew from a single cell or from a small clump of cells, so the result is reported in colony-forming units, or CFU, rather than in cells. As an example, suppose 156 colonies grow from 0.1 milliliter of the ten to the minus six dilution. We divide the colonies by the dilution times the volume plated, so 156 divided by ten to the minus seven gives 1.56 times ten to the ninth CFU per milliliter. Optical density gives a quick estimate of all the cells, and the plate count gives the number of living cells, the count we need when we test an antibiotic.

7:39 What antibiotics target

With growth and its measurement in place, we can turn to antibiotics and to the principle that makes them useful as medicines. A good antibiotic shows selective toxicity, which means it harms bacteria at concentrations the patient tolerates. To achieve selective toxicity, a drug must hit a structure or an enzyme that bacteria have and human cells lack, or have in a different form. The first such target is the cell wall, a mesh called peptidoglycan that surrounds the bacterial cell and holds it against its internal pressure, and human cells have no cell wall. The second target is the ribosome, the machine that builds proteins. Bacteria have 70S ribosomes, made of a small 30S subunit and a large 50S subunit, and the ribosomes in the cytoplasm of human cells are larger 80S particles with 40S and 60S subunits. The third target is a pair of enzymes, DNA gyrase and topoisomerase IV, which control the twisting of DNA while the bacterial chromosome is copied. The fourth target is the pathway that makes folic acid, or folate, which cells need to build nucleotides. Bacteria must make their own folate from a starting molecule called para-aminobenzoic acid, or PABA, while human cells take folate from food. The fifth target is the outer membrane of Gram-negative bacteria, which carries a large molecule called lipopolysaccharide. The main groups of antibiotics are organized around these five targets, and in the next section we take the groups one at a time.

9:14 How antibiotics work

Now that we know where the targets are, we can see what each group of antibiotics does to its target, starting with the cell wall. Peptidoglycan is built from long strands of two alternating sugars, N-acetylglucosamine and N-acetylmuramic acid, often shortened to NAG and NAM. Each NAM sugar carries a short peptide chain, and enzymes called penicillin-binding proteins, or PBPs, link the peptides of neighboring strands to each other. These cross-links turn separate strands into a strong mesh. Beta-lactam antibiotics, a group that includes the penicillins, the cephalosporins and the carbapenems, share a four-membered ring called the beta-lactam ring. A beta-lactam binds the penicillin-binding proteins and blocks the cross-linking step. A growing cell keeps cutting its old wall to insert new material, so without new cross-links the wall grows weaker, and the cell finally bursts under its own internal pressure. Vancomycin attacks the wall in a different way, by binding the D-alanyl-D-alanine end of the peptide on new building blocks, so the blocks cannot join the wall. Vancomycin is a large molecule that cannot cross the outer membrane of Gram-negative bacteria, so doctors use vancomycin against Gram-positive bacteria, including MRSA. The next group of drugs acts on protein synthesis at the 70S ribosome. Aminoglycosides, such as gentamicin and streptomycin, bind the 30S subunit and make the ribosome misread the messenger RNA, so the cell fills with faulty proteins. Tetracyclines also bind the 30S subunit, but they stop transfer RNAs carrying amino acids from entering the ribosome. Macrolides, such as erythromycin and azithromycin, bind the 50S subunit inside the exit tunnel, the channel the new protein leaves through, and the growing chain stops. DNA replication is the third target. As the replication machinery unwinds the double helix, the DNA ahead of the fork twists tighter, and DNA gyrase relieves this strain by cutting both strands, passing DNA through the gap and sealing the cut. Topoisomerase IV uses a similar cut to separate the two new chromosomes after copying. Fluoroquinolones, such as ciprofloxacin, trap these enzymes while the DNA is cut, so the breaks stay open and the cell dies. The folate pathway is the fourth target, and two drugs block the pathway at different steps. Sulfonamides resemble PABA, so they block dihydropteroate synthase, an early enzyme of the pathway that human cells do not have. Trimethoprim blocks a later enzyme, dihydrofolate reductase, and although human cells also have this enzyme, trimethoprim binds the bacterial version far more tightly. Doctors often give the two drugs together, as trimethoprim-sulfamethoxazole, to block two steps of the same pathway at once. Without folate, the cell cannot make the nucleotides it needs for DNA and RNA. The last target is the outer membrane of Gram-negative bacteria, where the polymyxins, polymyxin B and colistin, act. These positively charged molecules bind lipid A, the anchor of lipopolysaccharide, and disrupt the outer and inner membranes of Gram-negative bacteria, so the cell leaks its contents. Polymyxins can also damage the kidneys and nerves, so doctors keep polymyxins for infections that other drugs cannot treat. The main antibiotic groups therefore map onto the five targets, and the next step is to ask what each drug does to the population as a whole.

12:52 Killing or stopping growth

Knowing the target of a drug tells us only part of the story, because some antibiotics kill bacteria and others only stop bacterial growth. A bactericidal drug kills bacteria, and in the laboratory a drug counts as bactericidal when it lowers the number of living cells by 99.9 percent, a thousandfold drop, within 24 hours. A bacteriostatic drug stops bacteria from growing without killing most of the cells, and the patient's immune system then clears the infection. If we add each type of drug to a culture in log phase, the count falls after the bactericidal drug, and the curve levels off after the bacteriostatic drug. Among the drugs in the last section, aminoglycosides are bactericidal, and tetracyclines and most macrolides are bacteriostatic, although the line between the two groups also depends on the dose and on the organism. The growth curve also explains a key property of the beta-lactams. A beta-lactam blocks the cross-linking of new wall, so the drug does the most harm to cells that are building new wall. Cells in log phase grow and divide constantly, so they build new wall all the time, and beta-lactams kill these cells quickly. Cells in stationary phase grow slowly or not at all, so the same dose of a beta-lactam kills far fewer of these cells. To decide how much drug a bacterium can withstand, laboratories measure the minimum inhibitory concentration, or MIC. The MIC is the lowest concentration of an antibiotic that prevents visible growth after overnight incubation, usually 16 to 20 hours at 35 degrees Celsius. As an example, a row of eight tubes holds the drug in twofold dilutions, from 64 down to 0.5 micrograms per milliliter, and each tube receives the same number of bacteria. After incubation, the tubes with 1 and 0.5 micrograms per milliliter are cloudy, and the tube with 2 micrograms per milliliter is clear. The MIC is therefore 2 micrograms per milliliter, the lowest concentration with no visible growth. The laboratory then compares the MIC with a set value called a breakpoint, and it reports the strain as resistant when the MIC lies above the breakpoint. The MIC therefore puts a number on resistance, and the next section explains how bacteria reach a higher MIC.

15:19 How bacteria resist antibiotics

A resistant strain keeps growing at drug concentrations that stop susceptible strains of the same species, and bacteria reach this state in four main ways. The first way is to destroy the drug. Many bacteria make beta-lactamases, enzymes that cut open the beta-lactam ring, so the drug can no longer bind the penicillin-binding proteins. Some beta-lactamases destroy many different beta-lactams, including the carbapenems. Doctors can protect a beta-lactam by giving the drug with a beta-lactamase inhibitor, for example amoxicillin combined with clavulanic acid. The second way is to change the target so the drug no longer fits. Methicillin-resistant Staphylococcus aureus, or MRSA, carries a gene called mecA, which codes for an extra penicillin-binding protein named PBP2a. Beta-lactams bind PBP2a poorly, so PBP2a keeps cross-linking the wall while the drug is present, and the cell survives. In a similar way, mutations in DNA gyrase can lower the binding of fluoroquinolones. The third way is to pump the drug out. Efflux pumps are transport proteins in the membrane that push an antibiotic out of the cell faster than the drug builds up inside, and some pumps remove several classes of drugs. The fourth way is to keep the drug from getting in. Gram-negative bacteria take up many drugs through channel proteins called porins in the outer membrane, and a cell that makes fewer or altered porins lets less drug inside. Destroying the drug, changing the target, pumping the drug out and blocking its entry are the main mechanisms of resistance, which leaves the question of how a resistant cell becomes a resistant population.

17:04 How resistance spreads

A single resistant cell matters only if its resistance reaches many cells, and resistance reaches a population in two ways, through mutation and selection, and through gene transfer. Mutations arise by chance as cells copy their DNA, and they appear before any antibiotic is present. In a population of billions of cells, a few cells already carry a mutation that lowers the effect of a particular drug. When the antibiotic arrives, it kills the susceptible cells, and the rare resistant cells survive and multiply until they make up most of the population. The drug does not cause the mutation, but it selects the resistant cells, in the same way natural selection favors a trait that helps survival. Low doses and treatment courses that stop too early favor this selection, because they remove the most susceptible cells and leave the more resistant cells to grow. Bacteria can also gain resistance genes from other bacteria, even from other species, through horizontal gene transfer. In conjugation, a donor cell extends a thin appendage called a pilus to a recipient cell and passes the recipient a copy of a plasmid, a small circle of DNA separate from the chromosome. A single plasmid can carry several resistance genes, so one transfer can make the recipient resistant to several drugs at once. In transformation, a cell takes up free DNA released by dead bacteria, and in transduction, a bacteriophage, a virus that infects bacteria, carries a piece of bacterial DNA from one cell to the next. One more group of survivors needs a separate name, because these cells survive an antibiotic without being resistant. Persister cells are a small fraction of a population that is dormant or barely growing, so a drug that kills growing cells leaves the persisters alive. When the drug is gone, persisters grow again, and their offspring are as susceptible as the original population, with the same MIC. Persisters help explain why some infections return after treatment. Resistance therefore spreads through mutation with selection and through gene transfer, while persisters survive by resting in a state much like the stationary phase of the growth curve.

19:21 Review and question

Before the question, here is a brief review of the main ideas from this lesson. Bacteria divide by binary fission, and in a batch culture the population passes through the lag, log, stationary and death phases, which we measure with optical density and plate counts. Antibiotics act on targets that human cells lack or carry in a different form, the cell wall, the 70S ribosome, the DNA enzymes, the folate pathway and the outer membrane. Some drugs kill bacteria and others stop their growth, and the MIC measures how much drug a strain can withstand. Bacteria resist by destroying the drug, changing its target, pumping the drug out or keeping the drug out, and resistance genes spread through selection and gene transfer. Now here is a question to test what you learned. A culture in log phase and a culture in stationary phase receive the same dose of penicillin, so which culture loses more cells, and why? Please write your answer in the comments below. Back to the lesson. Whatever your answer, start from what penicillin blocks and which cells are building new wall when the drug arrives.

Read more

All videos